We investigatedthe use of a diode array detectorin conjunctionwith isocraticcation-exchangeliquid chromatography for detection of organic acids in urine. The spectra and retention times of abnormal peaks found on chromatography of urine from patients with methylmalonic aciduria, maple syrup urine disease, and lactic aciduna were recorded and compared wfth those obtained for group of pure organic acids. Our results show that diode array detection helpsconsiderablyin tentativelyidentifyingpeaks appearingon an abnormalchromatogramwhile awaiting confirmationby mass spectrometry.
Results

Spectra for Pure Organic Acids
We recorded the spectra between 190 and 250 am for a group of organic acids found in urine in health and disease, together with their retention times ( Table 1 ). All spectra were normalized by the computer, the absorbance axis being presented as a percentage of the maximum absorbance, thereby allowing direct comparison of the spectra of different compounds.
F'igure 1 shows the spectra for several organic acids. The spectrum for methyhnalonic acid (A), showing a depression at 195 am and a maximum absorbance between 205 and 208 urn, is similar to the spectra for citric, lactic, and x.-malic acids. However, subtle differences in the gradients of these spectra could be observed by superimposing them.
The spectrum for propionic acid (B) did not show the depression at 195 nrn as was found with methylmalonic acid. Similar spectra were obtained for adipic, isovaleric, glutaric, and succinic acids with a maximum absorbance between 205 and 207 am. We saw no peak in absorbance for a-ketoisocaproic (C), aketovaleric, or keto-f3-methyl-n-valeric acids in this region, all of which gave very similar spectra. Nor was there a peak in absorbance for gluconic and d-glucuronic acids CD),which gave identical spectra. 
Clinical Studies
Normal urines. Figure 2 depicts a typical chromatogram of a urine sample from a normal neonate. The spectra of the three major peaks generally found are also shown. The third (and major) peak gave a spectrum characteristic for uric acid, with two maximum absorption peaks at 230 and 283 am. Two maximum absorption peaks, at 205 and 262 am, were also observed for eluate corresponding to the second peak in the chromatogram, but this substance was not identified. Peak 1 had a retention time near that for glucuronic acid, but the corresponding spectrum differed from that of pure glucuronic acid (Figure 1, D) .
Methylmalonic aciduria. Figure 3 shows the chromatogram obtained for the urine from a patient with methylmalonic aciduria. An abnormal peak eluted at 9.38 miii, and The abnormalpeak (1), retentiontime 9.38 mm,is methylmalonicacid the spectrum for eluate corresponding to the apex of this peak was completely identical to that for pure methylmaionic acid (Figure 1, A) . Also, spectra taken at the ascending and descending slopes of this abnormal peak were identical to the spectrum obtained at the peak apex, confirming that this abnormal peak was a pure substance.
Maple syrup urine disease. Figure 4 shows the chromatogram for urine from a patient with maple syrup urine disease. Two abnormal peaks were seen at 12.15 and 14.49 miii, and the spectra of material in the eluate corresponding to these peaks were recorded. Retention times and spectra closely resembled those for a-keto-/3-methyl-n-vaieric acid and a-ketoisocaproic acid, respectively.
Lactic aciduria.
The chromatogram obtained from the urine of a patient with lactic aciduria secondary to liver -failure is shown in Figure 5 . In this case an abnormal peak eiuted at 10.60 mm was found; both the spectrum and retention of the peak were similar to those of the lactic acid standard.
Discussion
At present the identification of any peak on a chromatogram is based on its retention time, which can vary because of changes in ambient temperature and also batch variations in the mobile phase. Bennett and Bradey (7) have reported that the retention times of the method described here are very consistent from day to day. However, the closeness of the retention times of some organic acids complicates peak identification.
Our results show that the diode array detector adds considerable information towards the identification of abnormal peaks. The spectra of individual organic acids likely to occur in the urine of patients with organic aciduria can be recorded, stored on the computer, then overlayed onto the spectra obtained from the abnormal peaks on chromatograms from patients' samples. Combining this information with the retention times of the peaks helps in making a provisional diagnosis until the peak identity is confirmed by mass spectrometry.
